Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate
2007-06-19
2007-06-19
Saoud, Christine J. (Department: 1647)
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
C424S185100, C530S351000
Reexamination Certificate
active
10218338
ABSTRACT:
The present invention relates to hybrid interferon fusion proteins formed of an interferon-α protein where the C-terminal region of the interferon-α protein is replaced by a C-terminal region of interferon-τ. Also described are nucleic acid sequences encoding the interferon fusion proteins, expression vectors containing such sequences, and therapeutic applications of the interferon fusion proteins. The therapeutic applications include antiviral, anticellular proliferation, and anti-inflammatory applications. One advantage of the interferon fusion polypeptides of the present invention is that they have lower cytotoxic side effects when used to treat cells.
REFERENCES:
patent: 4276282 (1981-06-01), Sugimoto et al.
patent: 4414150 (1983-11-01), Goeddel
patent: 4456784 (1984-06-01), Goeddel
patent: 4460574 (1984-07-01), Yabrov
patent: 4507281 (1985-03-01), Asculai et al.
patent: 4569908 (1986-02-01), Mark et al.
patent: 4636383 (1987-01-01), Nagabhushan et al.
patent: 4758428 (1988-07-01), Mark et al.
patent: 4846782 (1989-07-01), Bonnem
patent: 4874609 (1989-10-01), Rideout et al.
patent: 4892743 (1990-01-01), Leibowitz et al.
patent: 4897471 (1990-01-01), Stabinsky
patent: 4917887 (1990-04-01), Hauptmann et al.
patent: 4997646 (1991-03-01), Hansen et al.
patent: 5019382 (1991-05-01), Cummins, Jr.
patent: 5705363 (1998-01-01), Imakawa
patent: 5738845 (1998-04-01), Imakawa
patent: 5939286 (1999-08-01), Johnson et al.
patent: 5958402 (1999-09-01), Bazer et al.
patent: 6174996 (2001-01-01), Johnson et al.
patent: 0 146 903 (1985-07-01), None
patent: 0 367 063 (1990-05-01), None
patent: WO 83/02461 (1983-07-01), None
patent: WO 90/09806 (1990-09-01), None
patent: WO 93/12146 (1992-12-01), None
patent: WO 94/10113 (1994-05-01), None
patent: WO 94/10313 (1994-05-01), None
patent: WO 97/33998 (1997-09-01), None
patent: WO 99/20653 (1999-04-01), None
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Wells, Aditivity of Mutational Effects in Proteins, 1990, Biochemistry, vol. 26, No. 37, pp. 8509-8517.
Bazer, F.W., and Johnson, H.M., “Type I Conceptus Interferons: Maternal Recognition of Pregnancy Signal and Potential Therapeutic Agents”,American J. of Reproductive Immun. 26:19-22 (1991).
Bazer, F.W., et al., “Roles of Conceptus Secretory products in Establishment of Pregnancy,”J. Reprod. Fert. 76:841-850.
Bazer, F.W., et al., “Roles of Ovine Trophoblast Protein-1 and Oestradiol/Prolactin in the Establishment of Pregnancy in Sheep and Pigs”,Reprod. Fertil. Dev. 4:335-340 (1992).
Bonnem, E.M., and Spiegel, R.J., “Interferon-α: Current Status and Future promise,”J. Biological Response Modifiers3:580-598 (1984).
Charpigny, G., et al. (1988)FEBS Lett. 228:12-16.
Farin, C.E. et al., “Expression of Trophoblastic Interferon Genes in Sheep and Cattle”,Biol. of Reprod. 43:210-218 (1990).
Godkin, et al., “Proteins Release by Cultured Day 15-16 Conceptuses Prolong Luteal Maintenance When Introduced into the Uterine Lumen of Cyclic Ewes,”J. Reprod. Fertil. 71:57-64 (1984).
Hansen, T.R., et al., “Complex Binding of the Embryonic Interferon, Ovine Trophoblast protein-1, to Endometrial Receptors”,J. Interferon Res. 9:215-225 (1989).
Hansen, T.R., et al., “The Gene for Trophoblast Interferons and the Related Interferon-α11 Possess Distinct 5′ promoter and 3′-Flanking Sequence”,J. Biol. Chem. 266(5):3060-3067 (1991).
Imakawa, K., et al., “Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm”, Nature 330:377-379 (1987).
Imakawa, K., et al., “Molecular Cloning and Characterization of Complementary Deoxyribonucleic Acids Corresponding to Bovine Trophoblast protein 1: A Comparison with Ovine Trophoblast Protein-1 and Bovine Interferon-α11”,Mol. Endocrin. 3(1):127-139 (1989).
Jarpe, M.A., et al., “Predicted Structural Motif of IFN τ ,”Prot. Engin. 7(7):863-867 (1994).
Leaman, D.W., et al. “Genes for Trophoblast Interferons and their Distribution among Mammals”,Reprod. Fertil. Dev. 4:349-353 (1992).
Leaman, D.W., and Roberts, R.M., “Genes for the Trophoblast Interferons in Sheep, Goat, and Musk Ox and Distribution of Related Genes Among Mammals”,J. Interferon Res. 12;1-11 (1992).
Li, J., and Roberts, R.M., “Structure-Function Relationships in the Interferon-τ (IFN-τ ): changes in Receptor binding and in Antiviral and Antiproliferative Activities Resulting from Site-Directed Multagenesis Performed Near the Carboxyl Terminus,”J. Biol. Chem269(40):248246-24833 (1994).
Newton, G.R., et al., “Inhibition of Lymphocyte Proliferation by Ovine Trophoblast Protein-1 and a High Molecular Weight Glycoprotein Produced by the Peri-Implantation Sheep Conceptus”,Am. J. Reprod. Immunol. 19:99-107 (1989).
Oldham, R.K. “Biologicals for Cancer Treatment: Interferons,”Hosp. Pract. Dec. 15. pp. 71-86 (1985).
Ott, T.L., et al., “Cloning and Expression inSaccharomyces cerevisiaeof a Synthetic Gene for the Type-I Trophoblast Interferon Ovine Trophoblast protein-1: Purification and Antiviral Activity”,J. Interferon Res. 11:357-364 (1991).
Pontzer, C.H., et al., “Antiviral Activity of the Pregnancy Recognition Hormone Ovine Trophoblast Protein-1”,Biochem. and Biophys. Res. Commun. 152(2):801-807 (1988).
Pontzer, C.H., et al., “Localization of an antiviral site on the pregnancy recognition hormone, ovine trophoblast protein-1”,Proc. Natl. Acad. Sci. USA87:5945-5949 (1990).
Pontzer, C.H., et al., “Antiproliferative Acticity of a Pregnancy Recognition Hormone, Ovine Trophoblast Protein-1”,Cancer Res. 51:5304-5307 (1991).
Pontzer, C.H., et al., “Structure/Function Studies with Interferon Tau:Evidence for Multiple Active Site,”J. Interferon Res. 14:133-141 (1994).
Quesada, J.R., et al., “Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia,”N. Engl. J. Med. 310:15-18 (1984).
Roberts, R.M., et al., “Interferons at the placenta interface”,J. Reprod. Fert., Suppl. 41:63-74 (1990).
Roberts, R.M., et al., “Unique Features of the Trophoblast Interferons”,Pharmac.Ther. 51:329-345 (1991a).
Roberts, R.M., et al., “The Polypeptides and genes for ovine and bovine trophoblast protein-1”,J. Reprod. Fert., Suppl. 43:-3-12 (1991b).
Roberts, R.M., et al., “Interferons as Hormones of Pregnancy”,Endocrine Rev. 13(3):432-452 (1992).
Salamonsen, L.A., et al., “Interferon-Alpha Mimics Effects of Ovine Trophoblast Protein 1 on Prostaglandin and Protein Secretion by Ovine Endometrial Cells in Vitro,”J. Endocrin. 117:R1-R04 (1988).
Stewart, H.J., et al. “Interferon Sequence Homology and Receptor Binding Activity of Ovine Trophoblast Antileuteolytic Protein,”J. Endicrinol. 115:R13-15 (1987).
Subramaniam, P.S., et al., “Differential Recognition of the Type I Interferon Receptor by Interferons τ and α is Responsible for Their Disparate Cytotoxicities,”Proc. Natl. Acad. Sci. USA92:12270-12274 (1995).
Subramaniam, P.S., and Johnson, H.M., “Differential Recognition of the Type I Receptor by the Type I Interferons, IFN τ and IFNα is Responsible for Their Differential Cytotoxicities,”FASEB J. 9(4):A1021 Abstract (1995).
Tuo, W., et al., “Natural Killer Cell Activity of Lymphocytes Exposed to Ovine, Type I, Trophoblast Interferon”,AJRI29:26-34(1993).
Vallet, J.L., et al., “The Effect of Ovine Trophoblast Protein0One on Endometrial Protein Secretion and Cyclic Nucleotides”,Biol. Reprod. 37:1307-1316 (1987).
Vallet, J.L., et al., “Effect of ovine conceptus secretory proteins and purified ovine trophoblast protein-1 on interoestrous interval and plasma concentrations of prostaglandins F-2α and E and 13, 14-dihydro-15-keto-prostaglandin F-2&#
Campos Jackeline
Li Wayne
Villarete Lorelie H.
Boyer Brian S.
Pepgen Corporation
Saoud Christine J.
Seharaseyon Jegatheesan
LandOfFree
Hybrid interferon/interferon tau proteins, compositions and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid interferon/interferon tau proteins, compositions and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid interferon/interferon tau proteins, compositions and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3859539